Pharmacodynamic study of CP-101

Trial Profile

Pharmacodynamic study of CP-101

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Dec 2015

At a glance

  • Drugs Aspirin/lisinopril/lovastatin (Primary)
  • Indications Cardiovascular disorders
  • Focus Pharmacodynamics
  • Sponsors CardioPharma
  • Most Recent Events

    • 17 Dec 2015 New trial record
    • 15 Dec 2015 According to CardioPharma media release, company is planning to start dosing of patients in the first quarter of 2016. This study has also received an FDA special protocol assessment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top